H

Hyloris Pharmaceuticals
HYL

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€177.72M
EV
€155.38M
Shares Outstanding
28.00M
Beta
0.32

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€12.50
P/E 2025E
-
P/Revenue 2025E
17.11x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Hyloris Pharmaceuticals SA

gainify

H

Hyloris Pharmaceuticals SA

HYL

Hyloris Pharmaceuticals SA engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs. The company offers Maxigesic IV, a combination of paracetamol and ibuprofen sodium dihydrate used for post-operative pain; Podof...

Sector

Healthcare

Industry

Biotechnology

CEO

Van Rompay, Stijn

Employees

49

IPO Date

2020-06-29

Headquarters

Boulevard Patience et Beaujonc N°3/1, Liège, Liège, 4000, Belgium

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved